E-cigarettes: controversies within the controversy

The Lancet Respiratory Medicine

Volumn 4, Issue 11, 2016, Pages 868-869

  Bareham, David ^a   Ahmadi, Keivan ^b   Elie, Mathieu ^b   Jones, Arwel W ^b  

^a Louth County Hospital   (United Kingdom)

^b UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BUTANEDIONE; ACETALDEHYDE; ACROLEIN; FORMALDEHYDE; NICOTINE;

ADVERTISING; BRONCHIOLITIS OBLITERANS; CANCER RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; ELECTRONIC CIGARETTE; HARM REDUCTION; HUMAN; LUNG CANCER; NICOTINE REPLACEMENT THERAPY; NOTE; PRIORITY JOURNAL; RISK REDUCTION; SMOKING CESSATION; TOBACCO INDUSTRY; UNITED KINGDOM; CONFLICT OF INTEREST; ETHICS; FEMALE; GLOBAL HEALTH; LEGISLATION AND JURISPRUDENCE; MALE; PUBLIC HEALTH; STATISTICS AND NUMERICAL DATA; VAPING;

CONFLICT OF INTEREST; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; GLOBAL HEALTH; HUMANS; MALE; PUBLIC HEALTH; SMOKING CESSATION; TOBACCO INDUSTRY; VAPING;

EID: 84994823955     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30312-5     Document Type: Note

References (0)